ATC/DDD

ATC/DDD index J05AR

You are here: Home > ATC/DDD > J > J05 > J05A

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- J
ANTIINFECTIVES FOR SYSTEMIC USE
- J05
ANTIVIRALS FOR SYSTEMIC USE
- J05A
DIRECT ACTING ANTIVIRALS

J05AR

Antivirals for treatment of HIV infections, combinations

ATC/DDD code J05AR for Antivirals for treatment of HIV infections, combinations

Combinations with pharmacokinetic enhancers are classified in this group, regardless of their antiviral effect. Plain products with cobicistat are classified in V03AX.

See list of DDDs for combination products, www.whocc.no.

J05AR01
zidovudine and lamivudine
J05AR02
lamivudine and abacavir
J05AR03
tenofovir disoproxil and emtricitabine
J05AR04
zidovudine, lamivudine and abacavir
J05AR05
zidovudine, lamivudine and nevirapine
J05AR06
emtricitabine, tenofovir disoproxil and efavirenz
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us